Sign in

CIK 0000874015

  • Large accelerated filer

IONIS PHARMACEUTICALS INC

Sign in to watch
Ticker
IONS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
330336973
Phone
+1 760-931-9200
Business address
2855 GAZELLE COURT, CARLSBAD, CA, 92010
Former names
ISIS PHARMACEUTICALS INC
Open-market buys, last 90 days
$148,200
in 1 filing
Open-market sales, last 90 days
$61,389
in 2 filings

Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-01 HOUGEN ELIZABETH L EVP, Finance & CFO Grant or award +4,140 95,030
2024-02-01 Geary Richard S EVP, Chief Development Officer Grant or award +3,820 89,295
2024-02-01 Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc Grant or award +4,140 37,950
2024-02-01 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award +3,609 80,932
2024-01-31 Swayze Eric EVP Research Sale 10b5-1 −10,773 $52.00 $560K 32,516
2024-01-25 Monia Brett P Chief Executive Officer Sale 10b5-1 −2,285 $51.75 $118K 151,851
2024-01-25 O'NEIL PATRICK R. EVP CLO & General Counsel Sale 10b5-1 −6,450 $51.75 $334K 46,802
2024-01-17 Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc Sale −5,564 $50.42 $281K 33,810
2024-01-17 O'NEIL PATRICK R. EVP CLO & General Counsel Sale −7,744 $50.42 $390K 53,252
2024-01-17 Birchler Brian EVP, Corp and Development Ops Sale −4,497 $50.42 $227K 44,582
2024-01-17 Swayze Eric EVP Research Sale −6,296 $50.42 $317K 43,289
2024-01-17 Swayze Eric EVP Research Sale −9 $50.42 $454 85
2024-01-17 Schneider Eugene EVP, Chf Clinical Develop Ofcr Sale −5,482 $50.42 $276K 47,850
2024-01-17 Monia Brett P Chief Executive Officer Sale −32,059 $50.42 $1.6M 154,136
2024-01-17 HOUGEN ELIZABETH L EVP, Finance & CFO Sale −8,683 $50.42 $438K 90,890
2024-01-17 Geary Richard S EVP, Chief Development Officer Sale −7,338 $50.42 $370K 85,475
2024-01-17 BENNETT C FRANK EVP, Chief Scientific Officer Sale −6,745 $50.42 $340K 77,323
2024-01-17 Baroldi Joseph EVP, Chief Business Officer Sale −1,460 $50.42 $74K 12,799
2024-01-17 Baroldi Joseph EVP, Chief Business Officer Sale −564 $50.42 $28K 1,640
2024-01-16 Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc Exercise or conversion +15,062 39,374

Page 41 of 44 · 873 trades